We detected a co‐occurrence of PPM1D and TP53 mutations when the VAF cutoff was 1%, aligning with a previous study indicating a significant co‐occurrence of PPM1D and TP53 mutations in t‐MDS [49]. This evidence concerns the gene TP53 and myelodysplastic syndrome.